Marc Delforge

929 total citations
45 papers, 515 citations indexed

About

Marc Delforge is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Marc Delforge has authored 45 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 18 papers in Epidemiology and 12 papers in Surgery. Recurrent topics in Marc Delforge's work include HIV/AIDS drug development and treatment (8 papers), HIV/AIDS Research and Interventions (7 papers) and Cervical Cancer and HPV Research (6 papers). Marc Delforge is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), HIV/AIDS Research and Interventions (7 papers) and Cervical Cancer and HPV Research (6 papers). Marc Delforge collaborates with scholars based in Belgium, Democratic Republic of the Congo and Germany. Marc Delforge's co-authors include Nathan Clumeck, Stéphane De Wit, Nicolás Dauby, Christine Gilles, Isabel Montesinos, Déborah Konopnicki, Stéphane De Wit, Francesco Feoli, Coca Necsoi and Patricia Barlow and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and AIDS.

In The Last Decade

Marc Delforge

39 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Delforge Belgium 14 235 207 113 81 73 45 515
Julián Olalla Spain 12 154 0.7× 232 1.1× 95 0.8× 64 0.8× 104 1.4× 69 534
Bernardino Roca Spain 14 153 0.7× 232 1.1× 95 0.8× 86 1.1× 55 0.8× 54 507
Ramesh Bhosale India 15 346 1.5× 407 2.0× 219 1.9× 74 0.9× 56 0.8× 39 651
Kristina Thorsteinsson Denmark 14 173 0.7× 153 0.7× 56 0.5× 116 1.4× 78 1.1× 28 361
Mallory D. Witt United States 14 454 1.9× 424 2.0× 68 0.6× 161 2.0× 137 1.9× 25 827
Tulika Singh United States 12 130 0.6× 228 1.1× 50 0.4× 60 0.7× 55 0.8× 39 480
Cindy Firnhaber South Africa 12 294 1.3× 238 1.1× 84 0.7× 85 1.0× 33 0.5× 19 515
Catherine Crenn‐Hébert France 12 162 0.7× 94 0.5× 98 0.9× 48 0.6× 28 0.4× 50 518
Helen E. Cejtin United States 14 252 1.1× 255 1.2× 79 0.7× 30 0.4× 111 1.5× 41 603
Nkeko Tshabangu United States 8 201 0.9× 184 0.9× 101 0.9× 18 0.2× 30 0.4× 10 334

Countries citing papers authored by Marc Delforge

Since Specialization
Citations

This map shows the geographic impact of Marc Delforge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Delforge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Delforge more than expected).

Fields of papers citing papers by Marc Delforge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Delforge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Delforge. The network helps show where Marc Delforge may publish in the future.

Co-authorship network of co-authors of Marc Delforge

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Delforge. A scholar is included among the top collaborators of Marc Delforge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Delforge. Marc Delforge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Touré, Yeya T., Charlotte Martin, Coca Necsoi, et al.. (2025). Experience of maternal immunization among women living with HIV in Belgium: A mixed-methods study. Preventive Medicine Reports. 54. 103107–103107.
2.
Florence, Éric, Jean Cyr Yombi, Sophie Henrard, et al.. (2023). Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real‐world setting in Belgium. HIV Medicine. 24(8). 914–924. 14 indexed citations
3.
Martin, Charlotte, Emmanuel Bottieau, Marc Delforge, & Nicolás Dauby. (2023). Do people living with HIV travel safely? Assessment of travel patterns and advice‐seeking behaviour in a cohort of people living with HIV in Belgium. HIV Medicine. 24(6). 754–759.
4.
Gilles, Christine, Serge Rozenberg, Frédéric Buxant, et al.. (2022). HPV genotyping in biopsies of HSIL and invasive cervical cancers in women living with HIV: A cohort- and a nested -case control study. Vaccine. 40(50). 7230–7237. 1 indexed citations
5.
6.
Vanderpas, Jean, et al.. (2021). Failure to eradicate Helicobacter pylori infection is more frequent among HIV‐positive patients. HIV Medicine. 22(7). 547–556. 7 indexed citations
7.
Florence, Éric, Michel Moutschen, Jean Cyr Yombi, et al.. (2021). Clinical characteristics and outcomes of COVID‐19 in people living with HIV in Belgium: A multicenter, retrospective cohort. Journal of Medical Virology. 93(5). 2971–2978. 8 indexed citations
8.
Gérard, Michèle, et al.. (2020). Infections due to carbapenemase-producing bacteria, clinical burden, and impact of screening strategies on outcome. Médecine et Maladies Infectieuses. 50(8). 658–664. 8 indexed citations
9.
Martin, Charlotte, Isabel Montesinos, Nicolás Dauby, et al.. (2020). Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk healthcare workers and hospital staff. Journal of Hospital Infection. 106(1). 102–106. 64 indexed citations
10.
Hites, Maya, Delphine Martiny, Evelyne Maillart, et al.. (2020). Invasive group B Streptococcus among non-pregnant adults in Brussels-Capital Region, 2005–2019. European Journal of Clinical Microbiology & Infectious Diseases. 40(3). 515–523. 30 indexed citations
11.
Delforge, Marc, et al.. (2020). Homeless people hospitalized with COVID-19 in Brussels. Clinical Microbiology and Infection. 27(1). 151–152. 16 indexed citations
12.
Hainaut, Marc, Patricia Barlow, Sigi Van den Wijngaert, et al.. (2019). High rate of rubella seronegativity in perinatally-infected HIV women of childbearing age: A case-control study. Vaccine. 37(40). 5930–5933. 2 indexed citations
13.
Libois, Agnès, Marie Hallin, Tania Crucitti, Marc Delforge, & Stéphane De Wit. (2018). Prevalence of Mycoplasma genitalium in men with urethritis in a large public hospital in Brussels, Belgium: An observational, cross-sectional study. PLoS ONE. 13(4). e0196217–e0196217. 15 indexed citations
14.
Libois, Agnès, Francesco Feoli, Marc Delforge, et al.. (2016). Prolonged antiretroviral therapy is associated with fewer anal high-grade squamous intraepithelial lesions in HIV-positive MSM in a cross-sectional study. Sexually Transmitted Infections. 93(1). 15–17. 18 indexed citations
15.
Konopnicki, Déborah, Yannick Manigart, Christine Gilles, et al.. (2015). High-risk human papillomavirus genotypes distribution in a cohort of HIV-positive women living in Europe. AIDS. 30(3). 1–1. 15 indexed citations
16.
Wit, Stéphane De, Vinciane Muls, Marc Delforge, et al.. (2015). HIV-Helicobacter pylori Co-Infection: Antibiotic Resistance, Prevalence, and Risk Factors. PLoS ONE. 10(12). e0145119–e0145119. 7 indexed citations
17.
Clumeck, Nathan, et al.. (2014). First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited setting. AIDS. 28(8). 1143–1153. 13 indexed citations
18.
Konopnicki, Déborah, Yannick Manigart, Christine Gilles, et al.. (2013). Sustained Viral Suppression and Higher CD4+ T-Cell Count Reduces the Risk of Persistent Cervical High-Risk Human Papillomavirus Infection in HIV-Positive Women. The Journal of Infectious Diseases. 207(11). 1723–1729. 61 indexed citations
19.
Wyndham-Thomas, Chloé, et al.. (2013). BARRIERS TO LIVER TRANSPLANTATION IN HIV INFECTED PATIENTS. Acta Clinica Belgica. 68(5). 349–355.
20.
Peeters, Martine, John N. Nkengasong, Betty Willems, et al.. (1995). Hiv-1 Group O Infection in Belgium. Acta Clinica Belgica. 50(3). 171–173. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julián Olalla Breakdown of academic impact, for papers by Bernardino Roca Breakdown of academic impact, for papers by Ramesh Bhosale Breakdown of academic impact, for papers by Kristina Thorsteinsson Breakdown of academic impact, for papers by Mallory D. Witt Breakdown of academic impact, for papers by Tulika Singh Breakdown of academic impact, for papers by Cindy Firnhaber Breakdown of academic impact, for papers by Catherine Crenn‐Hébert Breakdown of academic impact, for papers by Helen E. Cejtin Breakdown of academic impact, for papers by Nkeko Tshabangu
Rankless by CCL
2026